Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

WellCare Health, Fitbit Collaborate To Aid Diabetes Patients

Published 12/18/2019, 11:48 PM
Updated 07/09/2023, 06:31 AM

WellCare Health Plans, Inc.’s (NYSE:WCG) company WellCare of Georgia recently entered into a partnership with Fitbit, Inc. (NYSE:FIT) to provide Fitbit devices for WellCare Medicaid members in Georgia who are willing to control their diabetes level by taking their annual diabetic eye exams. WellCare's Fitbit Diabetes Program is the first Medicaid program that will include Fitbit.

Commencing Jan 1, 2020, Georgia Medicaid members aged 18 years and above who are enrolled in the Fitbit Diabetes Program, a Fitbit Inspire, will have access to diabetes diagnosis upon completion of their annual diabetic eye test. With this move, the company expects to help members manage their diabetes and other diseases that might occur from the same.

The combination of WellCare’s current range of management resources and Fitbit’s fitness tracker is expected to improve patient health outcomes. Many health insurers such as Anthem, Inc. (NYSE:ANTM) and Cigna Corporation (NYSE:CI) are using wearables as a preventive measure to track their member's health. Last year, Humana Inc (NYSE:HUM). also extended its multi-year partnership with Fitbit, to aid Humana's members in the employer group segment to adopt and implement healthy behaviors, which in turn would prevent and manage chronic health conditions.

Wearables are gaining prominence in the healthcare industry. They come in handy to track fitness and post-operative care of patients within a short span of time. Doctors are using wearables to keep track of patients’ health. Moreover, smart wearable sensors not only help in health monitoring but also in data analysis.

For health insurers, using wearables is a way to control medical claim costs, which would aid their margins.

As of Sep 30, 2019, the company served around 492,000 Medicaid members, 52,000 Medicare Advantage plan members and 26,000 Medicare Prescription Drug Plan members in Georgia.

Shares of this Zacks Rank #2 (Buy) company have surged 43.4% in a year’s time, outperforming its industry’s growth of 19%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.



Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft (NASDAQ:MSFT) in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Fitbit, Inc. (FIT): Free Stock Analysis Report

Cigna Corporation (CI): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

WellCare Health Plans, Inc. (WCG): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.